Gene Query: MRPL16

Dataset Description Geneva Score
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 30.11
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 22.43
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 21.91
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 20.71
Crizotinib v. DMSO in SW480 cells 16.78
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 14.69
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 14.09
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 14.08
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 14.04
Global analysis of enhancer targets: Mosaic-seq 12.65
Gene expression analysis of the impact of TDP-43 knockout in human cells. 12.56
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 12.44
Spliceosomal disruption of the non-canonical BAF complex in cancer 12.29
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 12.01
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 11.93
Human HAP1 cells before and after nutrient deprivation 11.93
Tracking of dCas9-methyltransferase footprints 11.74
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 11.64
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 11.03
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 11.03
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 10.73
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 10.61
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 10.61
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 10.38
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 10.13
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 10.11
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 10.05
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 10.02
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 10.01
RNA-seq of YB5 cells treated with Proscillaridin A 9.72
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 9.68
Developmental stage specific chromosome architecture in human erythroid cells 9.63
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 9.63
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 9.39
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 9.39
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 9.28
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 9.28
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 9.06
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 8.89
Comprehensive comparative analysis of 5’ end RNA sequencing methods 8.85
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 8.8
Transcriptional effect of ETV1 knockdown in melanoma cells 8.78
The evolution of N6-methyladenosine in primates 8.72
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 8.67
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 8.5
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 8.5
Single-cell analysis of adult human ovary using 10X genomics 8.5
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 8.38
The landscape of alternative splicing in aggressive prostate cancers 8.38
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 8.36
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 8.36
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 8.35
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 8.31
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 8.29
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 8.27
The comparison of high-throughput single-cell RNA-seq methods 7.87
DART-seq: an antibody-free method for global m6A detection 7.82
RNA sequencing of primary human platelets and in vitro cell lines 7.79
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 7.69
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 7.69
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 7.68
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 7.67
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 7.61
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 7.61
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 7.57
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 7.57
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 7.55
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 7.55
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 7.39
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 7.35
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 7.33
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 7.33
A transcriptome-wide divergence in protein translation scales with LIN28B expression 7.31
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 7.25
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 7.24
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 7.2
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 7.18
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 7.1
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 7.04
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 7.04
Genome wide expression change in LCC2 and MCF-7 cells 7.02
CROP-Seq in Primary Human T Cells 7.01
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 6.98
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 6.96
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 6.92
Effect of PRDM11 depletion in U2932 cells 6.85
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 6.81
Peptidomimetic blockade of MYB in acute myeloid leukemia 6.81
Impact of dieldrin on transcription in Jurkat T cells 6.78
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 6.77
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 6.77
hnRNP C is a key regulator of protein synthesis in mitosis 6.72
Transcriptome analysis in Neobractatin treated cells 6.72
Transcriptome analysis of H9 hESC derived cerebral organoids 6.72
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 6.68
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 6.57
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 6.48
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 6.47
Transcriptome analysis of U87 cells upon LINC00152 knockdown 6.47
Accurate annotation of human protein-coding small open reading frames 6.45
NRDE2 negatively regulates nuclear exosome functions 6.43
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 6.42
Rorc disruption in human FG pancreatic cancer cells 6.29
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 6.29
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 6.29
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 6.28
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 6.23
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 6.21
Differential gene expression of human melanoma cells [RNA-seq] 6.17
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 6.17
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 6.13
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 6.12
Generating Patterned Kidney Organoids for Studying Development and Diseases 5.93
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.89
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.89
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 5.88
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 5.77
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 5.77
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 5.76
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 5.76
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 5.76
RNA-seq of resting and activated CD4+ T cells +-JQ1 5.75
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 5.74
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 5.74
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 5.64
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 5.63
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 5.61
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 5.6
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 5.51
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 5.49
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 5.47
MYCi361 regulates MYC target genes 5.42
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 5.41
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 5.34
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 5.34
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 5.32
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 5.31
Genome-wide analysis of the Integrator complex 5.27
Genome-wide analysis of the Integrator complex (HTS) 5.27
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 5.22
snRNAs as regulators of alternative splicing 5.22
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 5.2
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.19
Transcriptional profiling of microglia; current state of the art and future perspectives 5.14
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 5.12
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 5.12
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 5.11
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 5.03
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.03
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 4.93
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 4.92
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 4.92
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.92
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 4.89
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.89
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 4.89
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 4.89
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 4.86
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 4.83
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 4.81
In situ CAPTURE of chromatin interactions by biotinylated dCas9 4.81
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 4.77
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 4.77
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 4.76
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 4.74
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 4.74
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 4.73
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 4.73
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 4.71
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 4.67
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 4.66
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 4.65
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 4.64
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 4.64
RNA-seq analysis of differentiating human erythroblasts 4.64
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 4.63
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 4.63
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 4.59
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 4.56
Co-transcriptional loading of RNA export factors shapes the human transcriptome 4.55
RNAseq of HEK293 cells after Chtop knockdown 4.55
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 4.55
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 4.54
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 4.54
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 4.53
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 4.52
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 4.51
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 4.49
RNA-seq analysis of RALD iPSCs after in vitro differentiation 4.48
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 4.45
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 4.44
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 4.43
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.43
A549 cells and MSR-A549 cells 4.42
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 4.42
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 4.4
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 4.4
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 4.39
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 4.39
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 4.37
Landscape and variation of RNA secondary structure across the human transcriptome 4.36
scRNASeq analysis of cycling cardiomyocytes 4.35
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 4.35
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 4.33
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 4.32
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 4.32
Human Treg IL-12 stimulation 4.26
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 4.21
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 4.2
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 4.19
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 4.19
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 4.19
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 4.19
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 4.14
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 4.11
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 4.11
Active translatome profiling with RiboLace in MCF7 cells 4.11
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 4.1
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 4.08
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 4.07
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 4.06
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 4.06
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 4.05
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 4.05
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 4.02
Trans-differentiation of human adult peripheral blood T cells into neurons 3.99
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 3.98
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.94
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.91
ARS2 is a general suppressor of pervasive transcription [RNAseq] 3.87
SLAM-seq for K562 endogenous mRNA decay 3.85
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 3.82
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.81
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 3.78
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 3.78
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.75
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 3.73
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.68
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.68
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.68
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.68
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 3.61
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 3.57
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 3.57
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.48
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 3.46
A map of gene expression in neutrophil-like cell lines 3.43
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.4
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 3.4
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 3.37
Effect of PBK knockdown on C4-2 cell transcriptome 3.34
mRNA expression profile of Lymphocytes 3.34
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 3.34
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 3.29
Cajal bodies are linked to genome conformation 3.2
Cajal bodies are linked to genome conformation [RNA-Seq] 3.2
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 3.18
PRDM1 inhibits proliferation of human colon cancer organoids 3.17
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 3.15
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 3.12
Gene expression analysis upon mtDNA depletion [RNA-seq] 3.11
Gene expression analysis upon mtDNA depletion 3.11
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 3.08
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 3.07
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 3.05
MeRIP-seq for heat shock in B-cell lymphoma cells 3.04
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.98
U2AF1 mutations alter splice site recognition in hematological malignancies 2.96
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 2.96
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 2.9
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 2.9
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.82
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 2.79
Retinoic acid suppresses MYB in adenoid cystic carcinoma 2.76
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 2.76
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.76
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 2.75
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 2.75
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 2.75
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 2.75
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 2.71
The cohesin complex prevents Myc-induced replication stress 2.71
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 2.7
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 2.7
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 2.7
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 2.7
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.7
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.69
Effect of CHKA knockdown on C4-2 cell transcriptome 2.66
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 2.61
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 2.61
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.58
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.54
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 2.53
SRSF1 role in cellular gene expression and splicing 2.51
RNA-seq of RKO cells with cTAZ KO or putback 2.5
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 2.5
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 2.5
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 2.49
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.48
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.47
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 2.45
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 2.45
Ribosome profiling upon inhibition of eIF4A 2.44
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.44
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 2.43
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 2.42
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 2.38
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 2.38
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 2.37
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.35
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.33
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.33
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 2.31
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 2.31
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 2.3
RNA editing in nascent RNA affects pre-mRNA splicing 2.29
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.27
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.27
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 2.27
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 2.26
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 2.23
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 2.19
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.17
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 2.17
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.15
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 2.15
miRNAs affected by antagomiR-17 treatment 2.09
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.06
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 2.05
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.03
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 2.01
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 1.99
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 1.96
RNA seq with AML (NB4) cells upon FTO inhibition 1.95
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 1.92
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.9
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.9
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.89
Functional significance of the HIV-1 Tat signature amino acid residues 1.86
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.86
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.82
The expression profiles of GBC liver metastasis 1.82
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 1.81
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 1.81
Transcriptome sequencing of K-562 cells 1.77
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.76
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.76
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.74
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.74
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.74
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.73
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 1.72
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.72
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.72
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.7
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.69
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.65
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 1.65
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 1.64
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.64
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 1.62
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 1.62
Transcriptional profiling of LS1034 cells treated with tepoxalin 1.59
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.59
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.58
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 1.58
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.53
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.53
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.49
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.49
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 1.49
Hepatosplenic T cell lymphoma 1.49
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.48
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.48
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.48
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 1.45
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.43
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.41
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.39
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.38
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 1.38
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.38
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.37
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 1.37
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 1.37
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.37
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.37
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.37
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.35
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.34
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.34
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.33
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.33
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.32
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.31
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.31
An siRNA screen identifies CHD4 as a target for epigenetic therapy 1.3
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 1.29
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.28
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.28
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 1.26
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 1.23
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 1.23
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.19
Discovering human diabetes-risk gene function with genetics and physiological assays 1.19
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.18
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.16
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.16
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.15
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.14
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.13
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.13
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.1
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.1
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 1.1
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.09
Gene expression signatures of innate lymphoid cells from human blood 1.07
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.07
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.07
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.06
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.06
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 1.05
The role of the Calcium-Sensing receptor in colorectal cancer 1.05
RNA-seq data 1.0
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.97
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.92
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.92
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 0.9
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.88
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.88
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.86
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.84
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.83
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 0.83
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.8
Human cells contain natural double-stranded RNAs with potential regulatory capacity 0.79
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.78
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.78
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.75
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.74
Impact on erythroid progenitor type on erythroid differntiation 0.73
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.73
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.73
Targeting MTHFD2 in Acute Myeloid Leukemia 0.72
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.71
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.67
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 0.66
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 0.66
The cohesin release factor WAPL restricts chromatin loop extension. 0.66
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 0.65
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 0.62
Comparative Analysis of Cas9 Activators Across Multiple Species 0.61
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.6
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.59
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.59
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.58
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.58
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 0.58
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.51
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.49
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.47
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.47
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.42
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.4
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.4
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.4
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.39
MHC Transcriptomic landscape at haplotype-specific resolution 0.38
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.38
RNA-Seq of PRMT1 overexpression ECA109 cells 0.37
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.37
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.37
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.33
The circadian transcriptional landscape in primary human mammary epithelial cells 0.3
K562 polyA RNA-Seq 0.29
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.29
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.29
Gene expression changes due to PARP knockdown in human cells 0.29
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.25
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.24
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.24
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.22
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.21
Transcriptional landscape changes during human embryonic stem cell derivation 0.18
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.17
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.14
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.13
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.12
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.1
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.1
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.1
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 0.09
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.08
Global transcriptome analysis of WT versus HEB-/- hESCs 0.07
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.05
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.04
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 0.04
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.04
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation